Frequently asked questions
North America held the largest proportion of the global market for automated endoscope reprocessors in terms of volume and value.
The need for endoscopy to diagnose and treat specific diseases is on the rise. Other factors driving the growth of this market include the aging population’s rising demand for endoscopic procedures, the increased focus by healthcare authorities on strengthening reprocessing guidelines, and the high risk of endoscope-associated infections caused by contaminated endoscopes.
Dual basin automated endoscopic reprocessors are anticipated to develop rapidly, with a CAGR of 6.8%, and have a market share of more than 50% by 2032.
Since endoscopic treatments in hospitals result in a high patient volume, endoscope reprocessing products are in higher demand in hospitals in 2021.